TY - JOUR
T1 - Risk factors for cardiovascular disease (CVD) in adults with type 1 diabetes
T2 - Findings from Prospective Real-life T1D Exchange Registry
AU - Shah, Viral N.
AU - Bailey, Ryan
AU - Wu, Mengdi
AU - Foster, Nicole C.
AU - Pop-Busui, Rodica
AU - Katz, Michelle
AU - Crandall, Jill
AU - Bacha, Fida
AU - Nadeau, Kristen
AU - Libman, Ingrid
AU - Hiers, Paul
AU - Mizokami-Stout, Kara
AU - DiMeglio, Linda A.
AU - Sherr, Jennifer
AU - Pratley, Richard
AU - Agarwal, Shivani
AU - Snell-Bergeon, Janet
AU - Cengiz, Eda
AU - Polsky, Sarit
AU - Mehta, Sanjeev N.
N1 - Funding Information:
Correspondence and Reprint Requests: Ryan Bailey, Jaeb Center for Health Research, 15310 Amberly Dr, Suite 350, Tampa, Florida 33647. E-mail: rbailey@jaeb.org Disclosure Summary: V.N.S.’s employer has received research funding from Jaeb Center for Health Research, Center for Women’ Health at the University of Colorado, National Institute of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Diabetes and Digestive and Kidney Diseases), Eyenuk, Sanofi US, Mylan, and Dexcom Inc., and received honoraria through the University of Colorado from Sanofi US and Dexcom Inc. R.B., M.W., N.C.F., R.P.B., M.K., J.C., F.B., K.N., I.L., P.H., K.M.S.., L.A.D., J.S., R.P., S.A., J.S.B., E.C., S.P., and S.N.M. have no relevant conflict of interests to disclose.
Publisher Copyright:
© Endocrine Society 2020. All rights reserved.
PY - 2020/5/1
Y1 - 2020/5/1
N2 - Context: Cardiovascular disease (CVD) is a major cause of mortality in adults with type 1 diabetes. Objective: We prospectively evaluated CVD risk factors in a large, contemporary cohort of adults with type 1 diabetes living in the United States. Design: Observational study of CVD and CVD risk factors over a median of 5.3 years. Setting: The T1D Exchange clinic network. Patients: Adults (age ≥ 18 years) with type 1 diabetes and without known CVD diagnosed before or at enrollment. Main Outcome Measure: Associations between CVD risk factors and incident CVD were assessed by multivariable logistic regression. Results: The study included 8,727 participants (53% female, 88% non-Hispanic white, median age 33 years [interquartile ratio {IQR} = 21, 48], type 1 diabetes duration 16 years [IQR = 9, 26]). At enrollment, median HbA1c was 7.6% (66 mmol/mol) (IQR = 6.9 [52], 8.6 [70]), 33% used a statin, and 37% used blood pressure medication. Over a mean follow-up of 4.6 years, 325 (3.7%) participants developed incident CVD. Ischemic heart disease was the most common CVD event. Increasing age, body mass index, HbA1c, presence of hypertension and dyslipidemia, increasing duration of diabetes, and diabetic nephropathy were associated with increased risk for CVD. There were no significant gender differences in CVD risk. Conclusion: HbA1c, hypertension, dyslipidemia and diabetic nephropathy are important risk factors for CVD in adults with type 1 diabetes. A longer follow-up is likely required to assess the impact of other traditional CVD risk factors on incident CVD in the current era.
AB - Context: Cardiovascular disease (CVD) is a major cause of mortality in adults with type 1 diabetes. Objective: We prospectively evaluated CVD risk factors in a large, contemporary cohort of adults with type 1 diabetes living in the United States. Design: Observational study of CVD and CVD risk factors over a median of 5.3 years. Setting: The T1D Exchange clinic network. Patients: Adults (age ≥ 18 years) with type 1 diabetes and without known CVD diagnosed before or at enrollment. Main Outcome Measure: Associations between CVD risk factors and incident CVD were assessed by multivariable logistic regression. Results: The study included 8,727 participants (53% female, 88% non-Hispanic white, median age 33 years [interquartile ratio {IQR} = 21, 48], type 1 diabetes duration 16 years [IQR = 9, 26]). At enrollment, median HbA1c was 7.6% (66 mmol/mol) (IQR = 6.9 [52], 8.6 [70]), 33% used a statin, and 37% used blood pressure medication. Over a mean follow-up of 4.6 years, 325 (3.7%) participants developed incident CVD. Ischemic heart disease was the most common CVD event. Increasing age, body mass index, HbA1c, presence of hypertension and dyslipidemia, increasing duration of diabetes, and diabetic nephropathy were associated with increased risk for CVD. There were no significant gender differences in CVD risk. Conclusion: HbA1c, hypertension, dyslipidemia and diabetic nephropathy are important risk factors for CVD in adults with type 1 diabetes. A longer follow-up is likely required to assess the impact of other traditional CVD risk factors on incident CVD in the current era.
UR - http://www.scopus.com/inward/record.url?scp=85082342512&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85082342512&partnerID=8YFLogxK
U2 - 10.1210/clinem/dgaa015
DO - 10.1210/clinem/dgaa015
M3 - Article
C2 - 31955209
AN - SCOPUS:85082342512
SN - 0021-972X
VL - 105
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 5
M1 - dgaa015
ER -